Moderna Seeks Full Authorization For COVID-19 Vaccine, Will Send Data To FDA

(CBS DETROIT) – Moderna wants full approval from the Food and Drug Administration for its COVID-19 vaccine.

Currently, its vaccine is only authorized for emergency use.

The company says it'll continue to submit trial data to the FDA on a rolling basis over the next few weeks.

Moderna is the second drugmaker to seek full authorization in the United States for a vaccine.

Pfizer applied for it last month.

© 2021 CBS Broadcasting Inc. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.